Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia

M. Bassetti, E. M. Trecarichi, A. Mesini, T. Spanu, D. R. Giacobbe, M. Rossi, E. Shenone, G. D. Pascale, M. P. Molinari, R. Cauda, C. Viscoli, M. Tumbarello

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset

Original languageEnglish
Pages (from-to)862-869
Number of pages8
JournalClinical Microbiology and Infection
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Bacteremia
Staphylococcus aureus
Delivery of Health Care
Mortality
Causality
Case-Control Studies
Morbidity
Therapeutics

Keywords

  • Healthcare-associated
  • Methicillin-resistance
  • Mortality
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Bassetti, M., Trecarichi, E. M., Mesini, A., Spanu, T., Giacobbe, D. R., Rossi, M., ... Tumbarello, M. (2012). Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection, 18(9), 862-869. https://doi.org/10.1111/j.1469-0691.2011.03679.x

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. / Bassetti, M.; Trecarichi, E. M.; Mesini, A.; Spanu, T.; Giacobbe, D. R.; Rossi, M.; Shenone, E.; Pascale, G. D.; Molinari, M. P.; Cauda, R.; Viscoli, C.; Tumbarello, M.

In: Clinical Microbiology and Infection, Vol. 18, No. 9, 09.2012, p. 862-869.

Research output: Contribution to journalArticle

Bassetti, M, Trecarichi, EM, Mesini, A, Spanu, T, Giacobbe, DR, Rossi, M, Shenone, E, Pascale, GD, Molinari, MP, Cauda, R, Viscoli, C & Tumbarello, M 2012, 'Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia', Clinical Microbiology and Infection, vol. 18, no. 9, pp. 862-869. https://doi.org/10.1111/j.1469-0691.2011.03679.x
Bassetti, M. ; Trecarichi, E. M. ; Mesini, A. ; Spanu, T. ; Giacobbe, D. R. ; Rossi, M. ; Shenone, E. ; Pascale, G. D. ; Molinari, M. P. ; Cauda, R. ; Viscoli, C. ; Tumbarello, M. / Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. In: Clinical Microbiology and Infection. 2012 ; Vol. 18, No. 9. pp. 862-869.
@article{d8c71b87fe854268b26fd06dd002d220,
title = "Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia",
abstract = "Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset",
keywords = "Healthcare-associated, Methicillin-resistance, Mortality, Staphylococcus aureus",
author = "M. Bassetti and Trecarichi, {E. M.} and A. Mesini and T. Spanu and Giacobbe, {D. R.} and M. Rossi and E. Shenone and Pascale, {G. D.} and Molinari, {M. P.} and R. Cauda and C. Viscoli and M. Tumbarello",
year = "2012",
month = "9",
doi = "10.1111/j.1469-0691.2011.03679.x",
language = "English",
volume = "18",
pages = "862--869",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier B.V.",
number = "9",

}

TY - JOUR

T1 - Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia

AU - Bassetti, M.

AU - Trecarichi, E. M.

AU - Mesini, A.

AU - Spanu, T.

AU - Giacobbe, D. R.

AU - Rossi, M.

AU - Shenone, E.

AU - Pascale, G. D.

AU - Molinari, M. P.

AU - Cauda, R.

AU - Viscoli, C.

AU - Tumbarello, M.

PY - 2012/9

Y1 - 2012/9

N2 - Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset

AB - Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset

KW - Healthcare-associated

KW - Methicillin-resistance

KW - Mortality

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=84865285121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865285121&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2011.03679.x

DO - 10.1111/j.1469-0691.2011.03679.x

M3 - Article

C2 - 21999245

AN - SCOPUS:84865285121

VL - 18

SP - 862

EP - 869

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 9

ER -